Cargando…
Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
The use of target agents and immune checkpoint inhibitors have changed the treatment landscape for AGC in the first-line setting. However, the crosswise comparison between each regimen is rare. Therefore, we estimated the efficacy and safety of targeted therapy or immunotherapy with chemotherapy in...
Autores principales: | Liu, Shu, Wong, Heung Yan, Xie, Li, Kim, Yoojin, Shu, Danhua, Zheng, Beishi, Liu, Naxin, Xing, Chungen, Chen, Xiaolei, Dong, Qiantong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768117/ https://www.ncbi.nlm.nih.gov/pubmed/36539429 http://dx.doi.org/10.1038/s41598-022-24426-9 |
Ejemplares similares
-
The Association Between Visceral Obesity and Postoperative Outcomes in Elderly Patients With Colorectal Cancer
por: Dong, Qiantong, et al.
Publicado: (2022) -
Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival
por: Sun, Li, et al.
Publicado: (2020) -
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022) -
Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review
por: Li, Lingling, et al.
Publicado: (2020) -
Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
por: Mashhadi, Mohammad Ali, et al.
Publicado: (2016)